Richard S. Lindahl - Feb 29, 2024 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
EVP, Chief Financial Officer
Signature
/s/ Jennifer Lynne Fox, Attorney-in-fact
Stock symbol
EBS
Transactions as of
Feb 29, 2024
Transactions value $
-$31,508
Form type
4
Date filed
3/4/2024, 06:42 PM
Previous filing
Feb 27, 2024
Next filing
Mar 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Tax liability -$29.2K -9.04K -5.36% $3.23 159K Feb 29, 2024 Direct F1
transaction EBS Common Stock Tax liability -$2.32K -684 -0.43% $3.39 159K Mar 1, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld to pay taxes.